-+ 0.00%
-+ 0.00%
-+ 0.00%

REZERA ANNOUNCES POSITIVE RESOLVE-2 PHASE 2 CLINICAL TRIAL RESULTS DEMONSTRATING FAVORABLE SAFETY AND TOLERABILITY PROFILE FOR RUVONOFLAST IN COMBINATION WITH SEMAGLUTIDE

Reuters·10/07/2026 12:00:20

Please log in to view news